ABCA1-mediated transport of cellular cholesterol and phospholipids to HBL apolipoproteins

Current Opinion in Lipidology

Volumn 11, Issue 3, 2000, Pages 253-260

  Oram, John F ^a   Vaughan, Ashley M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; CARRIER PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPID; STEROL;

ACTIVE TRANSPORT; ATHEROSCLEROSIS; BIOACCUMULATION; CELL TRANSPORT; CHOLESTEROL TRANSPORT; GENE MUTATION; HUMAN; MACROPHAGE; PRIORITY JOURNAL; PROTEIN METABOLISM; REVIEW; TANGIER DISEASE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CHOLESTEROL; HUMANS; LIGANDS; LIPOPROTEINS, HDL; PHOSPHOLIPIDS; TANGIER DISEASE;

EID: 0034115889     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200006000-00005     Document Type: Review

References (56)

1. 1 Oram JF, Yokoyama S. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J Lipid Res 1996; 37:2473-2491.
2. 2 Mendez AJ. Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion. J Lipid Res 1997; 38:1807-1821.
3. 3 Walter M, Gerdes U, Seedorf U, Assmann G. The high density lipoprotein-and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects. Biochem Biophys Res Commun 1994; 205:850-856.
4. 4 Francis GA, Knopp RH, Oram JF. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. J Clin Invest 1995; 96:78-87.
5. 5 Rogler G, Trumbach B, Klima B, Lackner KJ, Schmitz G. HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients. Arterioscler Thromb Vasc Biol 1995; 15:683-690.
6. 6 Marcil M, Yu L, Krimbou L, Boucher B, Oram JF, Cohn JS, Genest Jr J. Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency. Arterioscler Thromb Vasc Biol 1999; 19:159-169. Fibroblasts from individuals with familial HDL deficiency without the phenotype of Tangier disease have the same but less severe defect in apolipoprotein A-I-mediated lipid efflux as Tangier disease cells.
7. 7 Assmann G, von Eckardstein A, Brewer HB. Familial high density lipoprotein deficiency: tangier disease. In: Scriver CRT, Beaudet AL, Sly WS (editors). The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 1995. pp. 2053-2072.
8. 8 Rust S, Walter M, Funke H, von Eckardstein A, Cullen P, Kroes HY, et al. Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy [published erratum appears in Nat Genet 1998 Nov;20:312]. Nat Genet 1998; 20:96-98.
9. 9 Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999; 22:336-345. One of three papers in this journal issue, and the most comprehensive, to describe the discovery of ABCA1 as the defective Tangier disease gene. These authors also showed that some subjects with familial HDL deficiency have mutations in the same gene (See [10••] and [11••]).
10. 10 Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 1999; 22:347-351. The second in a series of three papers in the same journal issue to identify ABCA1 as the TD gene (See [9••] and [11••]).
11. 11 Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 1999; 22:352-355. The third in a series of papers to identify ABCA1 as the gene for Tangier disease(see [9••] and [10••]).
12. 12 Lawn RM, Wade DP, Garvin MR, Wang X, Schwarte K, Porter JG, et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 1999; 104:R25-31. These authors identified ABCA1 as the gene for Tangier disease using expression microarray analysis and presented several lines of evidence that this protein controls the apolipoprotein-mediated lipid removal pathway. They also showed that ABCA1 expression was regulated by both cholesterol and cAMP in fibroblasts, and that this protein appears on the cell surface.
13. 13 Luciani MF, Denizot F, Savary S, Mattei MG, Chimini G. Cloning of two novel ABC transporters mapping on human chromosome 9. Genomics 1994; 21:150-159.
14. 14 Langmann T, Klucken J, Reil M, Liebisch G, Luciani MF, Chimini G, et al. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun 1999; 257:29-33. Cloning of human ABCA1 DNA revealed striking nomology to the mouse DNA. ABCA1 is expressed ubiquitously in tissues, but at its highest in placenta, and is induced in macrophages by cholesterol.
15. 15 Klein I, Sarkadi B, Varadi A. An inventory of the human ABC proteins. Biochim Biophys Acta 1999; 1461:237-262. This is an excellent review of the family of human ABC transporters.
16. 16 Walker JE, Saraste M, Runswick MJ, Gay NJ. Distantly related sequences in the α and β subunits of ATP synthase, myosin, kinases and other ATP requiring enzymes and a common nucleotide binding fold. EMBO J 1982; 8:945-951.
17. 17 Broccardo C, Luciani M, Chimini G. The ABCA subclass of mammalian transporters. Biochim Biophys Acta 1999; 1461:395-404. An excellent review of the ABCA subfamily of ABC transporters.
18. 18 Marcil M, Brooks-Wilson A, Clee SM, Roomp K, Zhang LH, Yu L, et al. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet 1999; 354:1341-1346. Additional evidence that some individuals with familial HDL deficiency have ABCA1 mutations that cause defective cholesterol efflux. A pattern of multiple mutation sites is emerging.
19. 19 Remaley AT, Rust S, Rosier M, Knapper C, Naudin L, Broccardo C, et al. Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. Proc Natl Acad Sci USA 1999; 96:12685-12690. This study details the genomic organization of ABCA1 and describes the mutations in the original Tangier disease kindred.
20. 20 Mendez AJ, Uint L. Apolipoprotein-mediated cellular cholesterol and phospholipid efflux depend on a functional Golgi apparatus. J Lipid Res 1996; 37:2510-2524.
21. 21 Remaley AT, Schumacher UK, Stonik JA, Farsi BD, Nazih H, Brewer Jr HB. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler Thromb Vasc Biol 1997; 17:1813-1821.
22. 22 Mendez AJ, Anantharamaiah GM, Segrest JP, Oram JF. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J Clin Invest 1994; 94:1698-1705.
23. 23 Oram JF, Mendez AJ, Slotte JP, Johnson TF. High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts. Arterioscler Thromb 1991; 11:403-414.
24. 24 Mendez AJ, Oram JF, Bierman EL. Protein kinase C as a mediator of high density lipoprotein receptor- dependent efflux of intracellular cholesterol. J Biol Chem 1991; 266:10104-10111.
25. 25 Mollers C, Drobnik W, Resink T, Schmitz G. High-density lipoprotein and low-density lipoprotein-mediated signal transduction in cultured human skin fibroblasts. Cell Signal 1995; 7:695-707.
26. 26 Theret N, Delbart C, Aguie G, Fruchart JC, Vassaux G, Ailhaud G. Cholesterol efflux from adipose cells is coupled to diacylglycerol production and protein kinase C activation. Biochem Biophys Res Commun 1990; 173:1361-1368.
27. 27 Dusserre E, Pulcini T, Bourdillon MC, Berthezene F. High-density lipoprotein 3 stimulates phosphatidylcholine breakdown and sterol translocation in rat aortic smooth muscle cells by a phospholipase C/protein kinase C-dependent process. Biochem Med Metab Biol 1994; 52:45-52.
28. 28 Walter M, Reinecke H, Nofer JR, Seedorf U, Assmann G. HDL3 stimulates multiple signaling pathways in human skin fibroblasts. Arterioscler Thromb Vasc Biol 1995; 15:1975-1986.
29. 29 Garver WS, Deeg MA, Bowen RF, Culala MM, Bierman EL, Qram JF. Phosphoproteins regulated by the interaction of high-density lipoprotein with human skin fibroblasts. Arterioscler Thromb Vasc Biol 1997; 17:2698-2706.
30. 30 Drobnik W, Mollers C, Resink T, Schmitz G. Activation of phosphatidylinositol-specific phospholipase C in response to HDL3 and LDL is markedly reduced in cultured fibroblasts from Tangier patients. Arterioscler Thromb Vasc Biol 1995; 15:1369-1377.
31. 31 Walter M, Reinecke H, Gerdes U, Nofer JR, Hobbel G, Seedorf U, Assmann G. Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms. J Clin Invest 1996; 98:2315-2323.
32. 32 Drobnik W, Liebisch G, Biederer C, Trumbach B, Rogler G, Muller P, Schmitz G. Growth and cell cycle abnormalities of fibroblasts from Tangier disease patients. Arterioscler Thromb Vasc Biol 1999; 19:28-38. This study characterizes abnormal signaling in Tangier disease fibroblasts and its possible involvement in the slower proliferation of these cells.
33. 33 Orso E, Broccardo C, Kaminski WE, Bottcher A, Liebisch G, Drobnik W, et al. Transport of lipids from Golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice. Nat Genet 2000; 24:192-196. This is the first description of the phenotype of ABCA1 knockout mice, which closely resembles that of patients with Tangier disease. These mice will be useful in defining the role of ABCA1 in lipoprotein metabolism and atherogenesis. This study also confirms that ABCA1 is localized to the cell surface as well as the Golgi and presents evidence that mutations in ABCA1 impair lipid transport from the Golgi to the plasma membrane.
34. 34 Higgins CF, Gottesman MM. Is the multidrug transporter a flippase? Trends Biochem Sci 1992; 17:18-21.
35. 35 Oram JF, Brinton EA, Bierman EL. Regulation of high density lipoprotein receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells. J Clin Invest 1983; 72:1611-1621.
36. 36 Bielicki JK, Johnson WJ, Weinberg RB, Glick JM, Rothblat GH. Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol. J Lipid Res 1992; 33:1699-1709.
37. 37 Oram JF, Mendez AJ, Lymp J, Kavanagh TJ, Halbert CL. Reduction in apolipoprotein-mediated removal of cellular lipids by immortalization of human fibroblasts and its reversion by cAMP: lack of effect with Tangier disease cells. J Lipid Res 1999; 40:1769-1781. A description of the properties of immortalized normal and Tangier disease fibroblasts that were later used to characterize ABCA1 [12••]. The apolipoprotein-mediated lipid removal pathway in normal but not TD cells is induced by both cholesterol and a cAMP analog.
38. 38 Sakr SW, Williams DL, Stoudt GW, Phillips MC, Rothblat GH. Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-I by cAMP. Biochim Biophys Acta 1999; 1438:85-98. This study extends the work of Smith et al. [39] showing that cAMP analogs markedly induce apolipoprotein-mediated lipid removal from several murine macrophage lines but not from many other cultured cell lines. It also shows that apolipoprotein A-I directly binds to a 200 kD cell-surface protein that is induced by cAMP, providing the first hint that apolipoprotein A-I might bind directly to ABCA1.
39. 39 Smith JD, Miyata M, Ginsberg M, Grigaux C, Shmookler E, Plump AS. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors. J Biol Chem 1996; 271:30647-30655.
40. 40 Becq F, Hamon Y, Bajetto A, Gola M, Verrier B, Chimini G. ABC1, an ATP binding cassette transporter required for phagocytosis of apoptotic cells, generates a regulated anion flux after expression in Xenopus laevis oocytes. J Biol Chem 1997; 272:2695-2699.
41. 41 Kronqvist R, Leppimaki P, Mehto P, Slotte JP. The effect of interleukin 1 beta on the biosynthesis of cholesterol, phosphatidylcholine, and sphingomyelin in fibroblasts, and on their efflux from cells to lipid-free apolipoprotein A-I. Eur J Biochem 1999; 262:939-946.
42. 42 Francis GA, Tsujita M, Terry TL. Apolipoprotein A-I efficiently binds to and mediates cholesterol and phospholipid efflux from human but not rat aortic smooth muscle cells. Biochemistry 1999; 38:16315-16322.
43. 43 Asztalos B, Zhang W, Roheim PS, Wong L. Role of free apolipoprotein A-I in cholesterol efflux. Formation of pre-alpha-migrating high-density lipoprotein particles. Arterioscler Thromb Vasc Biol 1997; 17:1630-1636.
44. 44 Zhang W, Asztalos B, Roheim PS, Wong L. Characterization of phospholipids in pre-alpha HDL: selective phospholipid efflux with apolipoprotein A-I. J Lipid Res 1998; 39:1601-1607.
45. 45 Bielicki JK, McCall MR, Forte TM. Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage-like foam cells. J Lipid Res 1999; 40:85-92. Apolipoprotein A-I stimulates secretion of apolipoprotein E along with lipids from sterol-laden THP1 macrophages, and these apolipoproteins mostly associate with different lipidated particles.
46. 46 Ito J, Zhang LY, Asai M, Yokoyama S. Differential generation of high-density lipoprotein by endogenous and exogenous apolipoproteins in cultured fetal rat astrocytes. J Neurochem 1999; 72:2362-2369.
47. 47 Rees D, Sloane T, Jessup W, Dean RT, Kritharides L. Apolipoprotein A-I stimulates secretion of apolipoprotein E by foam cell macrophages. J Biol Chem 1999; 274:27925-27933. Both phospholipids and lipid-free apolipoprotein A-I can stimulate concomitant secretion of cholesterol and apolipoprotein E from macrophages.
48. 48 Hamon Y, Luciani MF, Becq F, Verrier B, Rubartelli A, Chimini G. Interleukin-1beta secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1. Blood 1997; 90:2911-2915.
49. 49 Hara H, Komaba A, Yokoyama S. Alpha-helical requirements for free apolipoproteins to generate HDL and to induce cellular lipid efflux. Lipids 1992; 27:302-304.
50. 50 Gillorte KL, Zaiou M, Lund-Katz S, Anantharamaiah GM, Holvoet P, Dhoest A, et al. Apolipoprotein-mediated plasma membrane microsolubilization. Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid. J Biol Chem 1999; 274:2021-2028. This comprehensive study uses different apolipoproteins, synthetic peptides, and deletion mutants to show that insertion of amphipathic helices into phospholipid bilayers is a required step for lipid removal by apolipoproteins. These findings also implicate lipid affinity as a critical determinant for apolipoprotein specificity.
51. 51 Yancey PG, Bielicki JK, Johnson WJ, Lund-Katz S, Palgunachari MN, Anantharamaiah GM, et al. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry 1995; 34:7955-7965.
52. 52 Gillotte KL, Davidson WS, Lund-Katz S, Rothblat GH, Phillips MC. Removal of cellular cholesterol by pre-beta-HDL involves plasma membrane microsolubilization. J Lipid Res 1998; 39:1918-1928.
53. 53 Rothblat GH, de la Llera-Moya M, Atger V, Kellner-Weibel G, Williams DL, Phillips MC. Cell cholesterol efflux: integration of old and new observations provides new insights. J Lipid Res 1999; 40:781-796. An excellent review which was written before the discovery of ABCA1 as a lipid transporter, describing the multiple mechanisms involved in the removal of cholesterol and phospholipids from cells by HDL components.
54. 54 Lin G, Oram JF. Apolipoprotein binding to protruding membrane domains during removal of excess cellular cholesterol. Atherosclerosis 2000; 149:359-370. Immunogotd electron microscopy shows that apolipoprotein A-I and apolipoprotein E interactions with cholesterol-loaded fibroblasts and macrophages form structures that protrude from the plasma membrane during lipid efflux by the ABCA1 pathway.
55. 55 Takahashi Y, Smith JD. Cholesterol efflux to apolipoprotein A-I involves endocytosis and resecretion in a calcium-dependent pathway [see comments]. Proc Natl Acad Sci USA 1999; 96:11358-11363. Using transport inhibitors and electron microscopy, this study revives an older hypothesis that HDL apolipoproteins remove cholesterol from macrophages by a retroendocytosis pathway.
56. 56 Serfaty-Lacrosniere C, Civeira F, Lanzberg A, Isaia P, Berg J, Janus ED, et al. Homozygous Tangier disease and cardiovascular disease. Atherosclerosis 1994; 107:85-98.